Adoptive immunotherapy in canine chimeras

Transplantation

Volumn 63, Issue 3, 1997, Pages 430-436

  Kolb, H J ^a,b   Gunther W ^a   Schumm, M ^a   Holler, E ^a,b   Wilmanns, W ^a,b   Thierfelder, S ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; LEUKOCYTE ANTIGEN; TETANUS TOXOID; THYMOCYTE ANTIBODY;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CHIMERA; CONTROLLED STUDY; DOG; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE TRANSFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN TRANSPLANTATION; T LYMPHOCYTE ACTIVATION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DOGS; FEMALE; GRAFT VS HOST DISEASE; IMMUNE TOLERANCE; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE TRANSFUSION; MALE; RADIATION CHIMERA; TETANUS TOXOID;

EID: 0342981457     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199702150-00017     Document Type: Article

References (34)

1. Kolb HJ, Rieder I, Rodt H, et al. Antilymphocytic antibodies and marrow transplantation: VI. Graft-versus-host tolerance in DLA-incompatible dogs after in vitro treatment of bone marrow with absorbed antithymocyte globulin. Transplantation 1979; 27: 242.
2. Apperley JF, Mauro FR, Goldman JM, et al. Bone marrow transplantation for chronic myeloid leukemia in first chronic phase: importance of a graft-versus-leukemia effect. Br J Haematol 1988; 69: 239.
3. Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555.
4. Deeg HJ, Raff RF, Grosse Wilde H, et al. Joint report of the Third International Workshop on Canine Immunogenetics: I. Analysis of homozygous typing cells. Transplantation 1986; 41: 111.
5. Nagler A, Ackerstein A, Or R, et al. Adoptive immunotherapy with mismatched allogeneic peripheral blood lymphocytes (PBL) following autologous bone marrow transplantation (ABMT) [Meeting abstract]. Exp Hematol 1992; 20: 705.
6. Abb J, Kolb HJ, Rodt H, Grosse-Wilde H, Rieder I, Thierfelder S. In vitro and in vivo immune response to specific antigens in canine marrow graft recipients. Z Immunitaetsforsch Immunobiol 1977; 153: 152.
7. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation, part I and II. N Engl J Med 1975; 292: 832, 895.
8. Storb R, Rudolph RH, Kolb HJ, et al. Marrow grafts between DLA-matched canine littermates. Transplantation 1973; 15: 92.
9. Rodt H, Thierfelder S, Eulitz M. Antilymphocytic antibodies and marrow transplantation: IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease. Exp Hematol 1974; 2: 195.
10. Vallera DA, Soderling CCB, Carlson GJ, Kersey JH. Bone marrow transplantation across major histocompatibility barriers in mice: effect of elimination of T cells from donor grafts by treatment with monoclonal Thy-1.2 plus complement or antibody alone. Transplantation 1981; 31: 218.
11. Schumm M, Günther W, Kolb HJ, et al. Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation. Tissue Antigens 1994; 43: 170.
12. Rodt H, Kolb HJ, Netzel B, et al. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation. Transplant Proc 1979; 11: 962.
13. Prentice HG, Janossy G, Price-Jones L, et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; 1: 472.
14. Hale G, Cobbold S, Waldman H. T cell depletion with Campath-1 in allogeneic bone marrow transplantation. Transplantation 1988; 45: 753.
15. Henslee PJ, Thompson JS, Romond EH, et al. T cell depletion of HLA identical and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-leukemia effect. Transplant Proc 1987; 19: 2701.
16. Aversa F, Tabilio A, Terenzi A, et al. Successful engraftment of T-cell depleted haploidentical "three loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948.
17. Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806.
18. Bretagne S, Vidaud M, Kuentz M, et al. Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms. Blood 1987; 70: 1692.
19. Singer JW, Keating A, Ramberg R, et al. Long-term stable hematopoietic chimerism following marrow transplantation for acute lymphoblastic leukemia: a case report with in vitro marrow culture studies. Blood 1983; 62: 869.
20. Kolb HJ, Rieder I, Grosse Wilde H, et al. Graft-versus-host disease (GVHD) following marrow grafts from DLA-matched canine litterniates. Transplant Proc 1979; 11: 507.
21. Weiden PL, Storb R, Tsoi M-S, Graham TC, Lerner KG, Thomas ED. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance. J Immunol 1976; 116: 1212.
22. Tutschka PJ, Ki PF, Beschorner WE, Hess AD, Santos GW. Suppressor cells in transplantation tolerance: II. Maturation of suppressor cells in the bone marrow chimera. Transplantation 1981; 32: 321.
23. Tutschka PJ, Hess AD, Beschorner WE, Santos GW. Suppressor cells in transplantation tolerance: I. Suppressor cells in the mechanism of tolerance in radiation chimeras. Transplantation 1981; 32: 203.
24. Tutschka PJ, Hess AD, Beschorner WE, Santos GW. Suppressor cells in transplantation tolerance: III. The role of antigen in the maintenance of transplantation tolerance. Transplantation 1982; 33: 510.
25. Sykes M, Sheard MA, Sachs DH. Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host of donor lymphohematopoietic cells. J Exp Med 1988; 168: 2391.
26. Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011.
27. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991; 324: 667.
28. Voogt PJ, Goulmy E, Veenhof WFJ, et al. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells. J Exp Med 1988; 168: 2337.
29. Gottlieb DJ, Cryz SJ Jr, Furer E, et al. Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients. Blood 1990; 76: 2470.
30. Lum LG, Seigneuret MC, Storb R. The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients. J Clin Immunol 1986; 6: 389.
31. Rouleau M, Senik A, Leroy E, Vernant JP. Long-term persistence of transferred PPD-reactive T cells after allogeneic bone marrow transplantation. Transplantation 1993; 55: 72.
32. Kato S, Yabe H, Yabe M, et al. Studies on transfer of varicellazoster virus specific T-cell immunity from bone marrow donor to recipient. Blood 1990; 75: 806.
33. Wimperis JZ, Brenner MK, Prentice HG, et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte depleted bone marrow. Lancet 1986; 1: 339.
34. Papadopoulos EB, Ladanyi M, Emanuel D, et al. Infusions of donor leukocytes to treat Epstein-Bar virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med 1994; 330: 1185.